Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance Podcast

Podcast | English | 2025 | 45 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This discussion takes the listener through the treatment of EGFR mutant NSCLC after acquired resistance to osimertinib.

Podcast Host:

Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Yasushi Goto, MD, National Cancer Center, Tokyo, Japan
Rachel Sanborn, MD, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR